David Samuel Dicapua Siegel, MD
Myeloma, Hematology Oncology
HMH-Oncology-Hackensack
92 Second Street, Hackensack, New Jersey 07601
Office Number
551-996-5900New Patient Visits
Online Booking
Dr. Siegel is one of the nation's foremost authorities on multiple myeloma (a blood cancer). His research has almost exclusively focused on multiple myeloma, and AL amyloidosis. He has been involved as a lead investigator in clinical trials of several medications that have become standard care for multiple myeloma. Founding Director of the Multiple Myeloma Institute, he and his team collaborate with other scientists and clinical researchers to pioneer more effective therapies for patients with this challenging disease.
About David
Specialties
Myeloma
Hematology Oncology
Gender
Male
Languages
English
Age groups seen
Adults
Adults Over 65
Education
Medical School
Memorial Sloan-Kettering Cancer Center
New York University School of Medicine
Certifications
Internal Medicine - American Board of Internal Medicine - 1989
Conditions Treated
genetic cancer risk assessment
undifferentiated embryonal sarcoma of the liver
transurethral resection of bladder
thrombotic thrombocytopenic purpura
thalassemia trait
testicular cancer chemotherapy
teratogen exposure
t-cell prolymphocytic leukemia
systemic mastocytosis
stem cell harvest
spherocytosis
secondary cancer screening
relapsed non hodgkin lymphoma
relapsed hodgkin lymphoma
relapsed acute myelogenous leukemia (aml)
relapsed acute lymphoblastic leukemia (all)
refractory cytopenia
refractory anemia with excess blasts
ras-associated autoimmune leukoproliferative disorder
prostate cancer chemotherapy
primary splenic lymphoma
primary effusion lymphoma
plasmacytoma
plasmablastic lymphoma
personal history of radiation therapy
personal history of chemotherapy
personal history of cancer
oral lesions
optic nerve glioma
nut carcinoma
nucleated red blood cell count
nodular lymphocyte predominant hodgkin lymphoma
neutrophilia
monomac syndrome
monocytosis
monoclonal b-cell lymphocytosis
mixed phenotype acute leukemia (mpal)
minimal residual disease
microsatellite instability
metastatic blood cancers
melanoma surgery
mediastinal lymphadenopathy
malignant granular cell tumor
maintenance chemotherapy
long term side effects of cancer treatment
light chain (al) amyloidosis
leukocytosis
kasabach merritt phenomenon (kmp)
inherited hematologic malignancies
induction chemotherapy
immune therapy
immune effector cell (iec) therapy
idh 1 mutation
hydroxyurea therapy
human t-cell lymphotropic virus type 2
human t-cell lymphotropic virus type 1
high iron
hereditary elliptocytosis (he)
hemophilia inhibitors
hemophilia carrier
hemophilia
gynecologic cancer genomics
giant platelet syndrome
gestational thrombocytopenia
germinoma
generalized lymphatic anomaly
follicular t-cell lymphoma
flt3 mutation
fibrolamellar carcinoma
familial amyloidosis
factor thirteen deficiency
factor seven deficiency
factor eight disorder
extranodal nk t cell lymphoma
evans syndrome
erythrocytosis
elevated transferrin saturation
elevated ferritin
egfr translocation
egfr mutation
consolidation chemotherapy
complement mediated hemolytic uremic syndrome
clonal cytopenia of undetermined significance
chronic neutrophilic leukemia
bronchus associated lymphoid tissue lymphoma
bone marrow stimulation
bone marrow harvest
bone marrow fibrosis
bone marrow aspiration
blood cancer chemotherapy
bleeding disorder clinics
blastic plasmacytoid dendritic cell neoplasm
bladder cancer chemotherapy
autoimmune neutropenia (ain)
autoimmune cytopenia
autoimmune (aa) amyloidosis
aids related malignancies
adult t cell lymphoma
adult t cell leukemia
adolescent and young adult cancer (aya)
adjuvant chemotherapy
acquired factor inhibitor
acquired elliptocytosis
abnormal protein
myeloproliferative diseases
myelodysplastic syndrome
aplastic anemia
blood disorders
lymphopenia
pernicious anemia
hemolytic anemia
retroperitoneal mass
non hodgkin lymphoma
lymphedema therapy
cancer related fatigue
bone marrow disorders
adverse effects to anticoagulants
thrombocytopenia
splenomegaly
sarcoma
polycythemia
plasma cell dyscrasia
petechiae
pancytopenia
musculoskeletal tumor
lymphoma
lung cancer
iron deficiency anemia
idiopathic thrombocytopenic purpura
cancer survivor
cancer pain
cancer chemotherapy
cancer
primary systemic amyloidosis
myelomalacia
myeloma kidney
metastatic bone disease
anemia and bone marrow disorders
waldenstrom macroglobulinemia
smoldering multiple myeloma
immunoglobulin replacement therapy
proteinuria
peripheral neuropathy
osteoporosis
lymphadenopathy
cardiac amyloid
bone tumor
bone disorders
anemia
bone marrow biopsy
hematologic malignancies
light chain disorders
multiple myeloma
neutropenia
leukopenia
blood cancer